Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Catalyst Health Ventures (CHV) is a Boston-based venture capital firm focused on early-stage investments in medical technology. Founded to support innovative healthcare solutions, CHV collaborates closely with entrepreneurs to navigate the complexities of the healthcare landscape. The firm primarily invests in companies at the seed through Series B stages.
CHV invests in early-stage companies developing breakthrough medical technologies, including therapeutic devices, digital health solutions, and diagnostics. The firm typically engages with businesses transitioning from pre-clinical to clinical development, emphasizing capital efficiency and scalable business models.
CHV's portfolio includes notable companies such as Veracyte, Inc. (NASDAQ: VCYT), Boston Scientific (NYSE: BSX), Agilent Technologies (NYSE: A), Life Technologies (NYSE: TMO), Medline Systems, and AngioDynamics (NASDAQ: ANGO), all of which have been acquired by leading firms in the MedTech sector.
Submit your pitch through their form at chv.vc or email info@chv.vc with your deck.
As of October 2023: CHV has been active in promoting its portfolio, including the commercial launch of Instylla's Embrace™ Hydrogel Embolic System and the promotion of David Mackey to Partner.
CHV often leads funding rounds, particularly in early-stage investments where they can provide significant support and resources to startups.
CHV is open to follow-on investments, especially for companies that demonstrate strong growth and capital efficiency in their development stages.
The specific size of CHV's current fund is not publicly disclosed, but they focus on early-stage investments typically ranging from seed to Series B funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.